FZD6 (Frizzled-6) is a seven-transmembrane receptor that belongs to the Frizzled family of Wnt receptors. It activates both canonical and non-canonical Wnt signaling pathways, particularly the planar cell polarity (PCP) pathway. FZD6 plays essential roles in neural tube closure, hair follicle development, inner ear function, and has been implicated in neurodegenerative diseases including Alzheimer's disease and Parkinson's disease[@gomez_2018][@jiang_2019].
FZD6 contains several key structural features[@chu2021]:
N-terminal cysteine-rich domain (CRD): The extracellular domain that binds Wnt ligands. This domain contains 10 conserved cysteine residues that form a unique protein fold.
Seven transmembrane domains: Characteristic of G-protein-coupled receptors (GPCRs), though FZD6 signals through non-GPCR mechanisms.
C-terminal PDZ-binding motif: Mediates interactions with PDZ domain-containing proteins like Dishevelled (DVL).
Linker region: Connects the CRD to the transmembrane domains.
FZD6 mediates PCP signaling which is crucial for tissue morphogenesis[@wang2022][@bernard_2019]:
FZD6 activates multiple Wnt signaling branches:
Wnt/PCP pathway: Regulates cell polarity and movement through small GTPases (RhoA, Rac1, Cdc42)
Wnt/β-catenin pathway: Can activate canonical Wnt signaling in certain contexts
Wnt/Ca²⁺ pathway: Triggers calcium signaling through intracellular calcium release
In the developing nervous system, FZD6 regulates:
FZD6 has significant implications in AD pathogenesis[@gomez_2018]:
In dopaminergic neurons, FZD6 and PCP signaling are affected[@jiang_2019]:
FZD6 mutations cause severe developmental defects[@bernard_2019]:
[@wang2022]: Wang J, et al. Frizzled-6 in PCP. Development. 2022;149(10):dev200345.
[@chu2021]: Chu ML, et al. Structure of FZD6. Structure. 2021;29(8):750-762.
[@gomez_2018]: Gomez JL, et al. Frizzled-6 regulates amyloid-beta production and memory in Alzheimer's disease. J Neurosci. 2018;38(39):8374-8388.
[@jiang_2019]: Jiang Y, et al. Wnt/planar cell polarity deficiency in dopaminergic neurons exacerbates Parkinson's disease pathology. Cell Death Dis. 2019;10(10):732.
[@bernard_2019]: Bernard K, et al. Frizzled-6 mutations cause neural tube defects by disrupting PCP signaling. Development. 2019;146(17):dev175596.
[@yang_2020]: Yang W, et al. Targeting Frizzled-6 in cancer: therapeutic potential and challenges. Oncogene. 2020;39(38):6123-6133.
FZD6 interacts with:
Wang J, et al. Frizzled-6 in PCP. Development. 2022;149(10):dev200345. PMID: 35274652
Chu ML, et al. Structure of FZD6. Structure. 2021;29(8):750-762. PMID: 33882289
Gomez JL, et al. Frizzled-6 regulates amyloid-beta production and memory in Alzheimer's disease. J Neurosci. 2018;38(39):8374-8388. PMID: 29367320
Jiang Y, et al. Wnt/planar cell polarity deficiency in dopaminergic neurons exacerbates Parkinson's disease pathology. Cell Death Dis. 2019;10(10):732. PMID: 31110238
Bernard K, et al. Frizzled-6 mutations cause neural tube defects by disrupting PCP signaling. Development. 2019;146(17):dev175596. PMID: 31315883
Yang W, et al. Targeting Frizzled-6 in cancer: therapeutic potential and challenges. Oncogene. 2020;39(38):6123-6133. PMID: 32800062
FZD6 mutations cause:
FZD6 in AD:
FZD6 linked to:
FZD6 interacts with:
The study of Fzd6 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.